Work

Abstract PS5-01-11: Impact of antiemetic strategy on overall survival in patients with metastatic HER2-positive breast cancer treated with trastuzumab deruxtecan: A real-world retrospective study

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-01-11

Authors: S. Reganti, R. Choksi, F. Kudrik, D. Patt, S. Reddy, S. Rosenfeld, D. Parris, G. Rahimi, A. Rui, M. Gart, C. Wall, B. Wang, P. Varughese, J. Donegan, L. Morere, R. Geller, J. Scott, V. Gorantla

Institutions: University of Pittsburgh Medical Center, South Carolina Oncology Associates, Texas Oncology, Highlands Oncology Group, Integra (United States)

Language: English

Topic: Nausea and vomiting management

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129490968

Cites:

Cited by:

Related to: